FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

772032008: Burosumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3708082013 Burosumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3708083015 Burosumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3708082013 Burosumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3708083015 Burosumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5526101000241114 burosumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5526101000241114 burosumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Burosumab Is a Monoclonal immunoglobulin G (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing burosumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Burosumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Burosumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only burosumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Burosumab 30 mg/mL solution for injection Has basis of strength substance (attribute) True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Burosumab 30 mg/mL solution for injection Has precise active ingredient True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Burosumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start